- Current status and outcome of liver transplantation in South Korea
-
Choi HJ
- KMID: 2523875
- Clin Mol Hepatol.
- 2022 Jan;28(1):117-119.
- doi: 10.3350/cmh.2021.0381
-
- CITED
-
- Close
- SHARE
-
- Close
- Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment
-
Kwon JY
- KMID: 2523870
- Clin Mol Hepatol.
- 2022 Jan;28(1):50-51.
- doi: 10.3350/cmh.2021.0359
-
- CITED
-
- Close
- SHARE
-
- Close
- Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
-
Lee SM, Kim W
- KMID: 2523869
- Clin Mol Hepatol.
- 2022 Jan;28(1):47-49.
- doi: 10.3350/cmh.2021.0338
-
- CITED
-
- Close
- SHARE
-
- Close
- Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes
-
El Jamaly H, Eslick GD, Weltman M
- KMID: 2523871
- Clin Mol Hepatol.
- 2022 Jan;28(1):52-66.
- doi: 10.3350/cmh.2021.0205
Background/Aims: Maternal and fetal outcomes in pregnant patients with Non-alcoholic fatty liver disease (NAFLD) have been largely unexplored. To determine the level of evidence associated with maternal and fetal outcomes... -
- CITED
-
- Close
- SHARE
-
- Close
- Current knowledge about biomarkers of acute kidney injury in liver cirrhosis
-
Lee HA, Seo YS
- KMID: 2523868
- Clin Mol Hepatol.
- 2022 Jan;28(1):31-46.
- doi: 10.3350/cmh.2021.0148
Acute kidney injury (AKI) is common in advanced cirrhosis. Prerenal azotemia, hepatorenal syndrome, and acute tubular necrosis are the main causes of AKI in patients with cirrhosis. Evaluation of renal... -
- CITED
-
- Close
- SHARE
-
- Close
- Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
-
An J, Kim HD, Kim SO, Kim HI, Song GW, Lee HC, Shim JH
- KMID: 2523872
- Clin Mol Hepatol.
- 2022 Jan;28(1):67-76.
- doi: 10.3350/cmh.2021.0202
Background/Aims: We aimed to investigate the silent atherosclerotic burden of cervicocephalic vessels in cirrhotic patients compared with the general population, as well as the relevant risk factors including coronary parameters. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
-
Kim SW, Yoon JS, Lee M, Cho Y
- KMID: 2523867
- Clin Mol Hepatol.
- 2022 Jan;28(1):17-30.
- doi: 10.3350/cmh.2021.0093
Hepatitis B virus (HBV) affects approximately 250 million patients worldwide, resulting in the progression to cirrhosis and hepatocellular carcinoma, which are serious public health problems. Although universal vaccination programs exist,... -
- CITED
-
- Close
- SHARE
-
- Close
- The management of post-transplantation recurrence of hepatocellular carcinoma
-
Rajendran L, Ivanics T, Claasen MP, Muaddi H, Sapisochin G
- KMID: 2523866
- Clin Mol Hepatol.
- 2022 Jan;28(1):1-16.
- doi: 10.3350/cmh.2021.0217
The annual incidence of hepatocellular carcinoma (HCC) continues to rise. Over the last two decades, liver transplantation (LT) has become the preferable treatment of HCC, when feasible and strict selection... -
- CITED
-
- Close
- SHARE
-
- Close
- A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
-
Kim HL, Kim KA, Choi GH, Jang ES, Ki M, Choi HY, Jeong SH
- KMID: 2523874
- Clin Mol Hepatol.
- 2022 Jan;28(1):91-104.
- doi: 10.3350/cmh.2021.0236
Background/Aims: This study aimed to evaluate the cost-effectiveness of hepatitis C virus (HCV) screening compared to no screening in the Korean population from societal and healthcare system perspectives. Methods: A published... -
- CITED
-
- Close
- SHARE
-
- Close
- U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
-
Lin H, Wong GLH, Zhang X, Yip TCF, Liu K, Tse YK, Hui VWK, Lai JCT, Chan HLY, Wong VWS
- KMID: 2523873
- Clin Mol Hepatol.
- 2022 Jan;28(1):77-90.
- doi: 10.3350/cmh.2021.0188
Background/Aims: We aimed to determine the association between blood urea level and incident cirrhosis, hepatic decompensation, and hepatocellular carcinoma in chronic liver disease (CLD) patients. Methods: The association between blood urea... -
- CITED
-
- Close
- SHARE
-
- Close
